Publications of Sophie Gatineau-Sailliant
Bookmark and Share    
Full Text
See detailQuel suivi après un cancer pédiatrique ? L’expérience de la consultation SALTO.
FOHN, Anaîs ULiege; Quenon, C.; Jacquemin, C. et al

in Revue medicale de Liege (2021), 76(5-6), 535-540

During the past 50 years, the mortality due to childhood cancers decreased dramatically thanks to improvements in supportive care and the use of multimodal approaches. In this context, the long-term ... [more ▼]

During the past 50 years, the mortality due to childhood cancers decreased dramatically thanks to improvements in supportive care and the use of multimodal approaches. In this context, the long-term follow up after childhood cancer has become a main concern for pediatric oncologists. The SALTO programme was developed in 2012 at the CHR Citadelle in Liège in order to organize a multidisciplinary long-term follow-up for the patients previously treated in our department for a childhood cancer. The aim of the present study was to review, for the most frequent childhood cancers, the long-term sequellae and the second cancers developed by the patients participating to the SALTO programme in order to define the follow-up needed. Our data confirm the importance of a multidisciplinary long-term follow-up, based on the treatments received and following international guidelines. [less ▲]

Detailed reference viewed: 28 (8 ULiège)
Full Text
See detailL'essor des thérapies ciblées en oncologie pédiatrique
DRESSE, Marie-Françoise ULiege; David, Bianca-Andreea ULiege; Demarche, Martine ULiege et al

in Revue Médicale de Liège (2021)

Detailed reference viewed: 52 (12 ULiège)
Full Text
See detailImpact of DARC, GSDMA and CXCL2 polymorphisms on induction toxicity in children with acute lymphoblastic leukemia: A complementary study.
Gatineau-Sailliant, Sophie ULiege; Glisovic, Sanja J.; Gagne, Vincent et al

in Leukemia Research (2019), 86

Detailed reference viewed: 33 (1 ULiège)
Full Text
See detailLangerhans Cell Histiocytosis With Vertebral Involvement Diagnosed and Treated Over the Last 15 Years in a Single Canadian Pediatric Academic Institution.
Gatineau-Sailliant, Sophie ULiege; Grimard, Pascale; Miron, Marie-Claude et al

in Journal of pediatric hematology/oncology (2019)

We report 11 children with vertebral lesion of Langerhans cell histiocytosis (LCH) diagnosed and treated between 2000 and 2015. Vertebral lesions were usually present at LCH diagnosis. No child developed ... [more ▼]

We report 11 children with vertebral lesion of Langerhans cell histiocytosis (LCH) diagnosed and treated between 2000 and 2015. Vertebral lesions were usually present at LCH diagnosis. No child developed neurological symptoms. Among 29 vertebral lesions, only 2 were unstable. Chemotherapy was used in all children but 3. A LCH recurrence was observed in 6 patients, involving vertebrae in 4 cases. All children were disease-free at their last follow-up. Sequelae were more often radiologic than clinical. Since potential recurrences and incomplete bone regeneration exist, discussion about optimal treatment and long-term follow-up of vertebral lesions are essential. [less ▲]

Detailed reference viewed: 33 (1 ULiège)
Full Text
See detailGray Zone Lymphoma Arising in the Neck of a Teenager With a Germline Mutation in TP53.
Gatineau-Sailliant, Sophie ULiege; Turcotte, Karine; Quintal, Marie-Claude et al

in Journal of Pediatric Hematology/Oncology (2018)

Gray zone lymphoma is an aggressive disease for which appropriate management is still debated. We report a 15-year-old girl with a cervical mass, an enlarged ipsilateral tonsil, and anemia. Both sites ... [more ▼]

Gray zone lymphoma is an aggressive disease for which appropriate management is still debated. We report a 15-year-old girl with a cervical mass, an enlarged ipsilateral tonsil, and anemia. Both sites showed hypermetabolism on F18-FG positron emission tomography/CT. Surgical resection was diagnostic of Epstein-Barr virus-negative gray zone lymphoma cervical and tonsillar involvement. No abnormality was found in cytogenetic analysis on tumor cells. However, exome sequencing in peripheral blood DNA revealed a germline mutation in TP53. Complete response was achieved after surgery and 6 cycles of rituximab with dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen. [less ▲]

Detailed reference viewed: 30 (1 ULiège)